Exendin-4 inhibits high glucose-induced oxidative stress in retinal pigment epithelial cells by modulating the expression and activation of p⁶⁶Shc

References

• Hendrick AM, Gibson MV, Kulshreshtha A. Diabetic retinopathy. Prim Care 2015;42:451–464.
   PubMed Web of Science ®Google Scholar
• Lu L, Jiang Y, Jaganathan R, Hao Y. Corrigendum to "current advances in pharmacotherapy and technology for diabetic retinopathy: a systematic review". J Ophthalmol 2018;5047142.
   PubMed Web of Science ®Google Scholar
• Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol 2012;60:428–431.
   PubMed Web of Science ®Google Scholar
• Steinberg RH. Interactions between the retinal pigment epithelium and the neural retina. Doc Ophthalmol 1985;60:327–346.
   PubMed Web of Science ®Google Scholar
• Decanini A, Karunadharma PR, Nordgaard CL, et al. Human retinal pigment epithelium proteome changes in early diabetes. Diabetologia 2008;51:1051–1061.
   PubMed Web of Science ®Google Scholar
• Sparrow JR, Hicks D, Hamel CP. The retinal pigment epithelium in health and disease. Curr Mol Med 2010;10:802–823.
   PubMed Web of Science ®Google Scholar
• Klettner A. Oxidative stress induced cellular signaling in RPE cells. Front Biosci (Schol Ed) 2012;4:392–411.
   PubMedGoogle Scholar
• Xu HZ, Song Z, Fu S, et al. RPE barrier breakdown in diabetic retinopathy: seeing is believing. J Ocul Biol Dis Infor 2011;4:83–92.
   PubMedGoogle Scholar
• Xia T, Rizzolo LJ. Effects of diabetic retinopathy on the barrier functions of the retinal pigment epithelium. Vision Res 2017;139:72–81.
   PubMed Web of Science ®Google Scholar
• Dai C, Jiang S, Chu C, et al. Baicalin protects human retinal pigment epithelial cell lines against high glucose-induced cell injury by up-regulation of microRNA-145. Exp Mol Pathol 2019;106:123–130.
   PubMed Web of Science ®Google Scholar
• Zhang X, He N, Xing Y, Lu Y. Knockdown of GCN2 inhibits high glucose-induced oxidative stress and apoptosis in retinal pigment epithelial cells. Clin Exp Pharmacol Physiol 2020;47:591–598.
   PubMed Web of Science ®Google Scholar
• Farnoodian M, Halbach C, Slinger C, et al. High glucose promotes the migration of retinal pigment epithelial cells through increased oxidative stress and PEDF expression. Am J Physiol Cell Physiol 2016;311:C418–436.
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Chan P-S. Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007;2007:43603.
   PubMedGoogle Scholar
• Busik JV, Mohr S, Grant MB. Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes 2008;57:1952–1965.
   PubMed Web of Science ®Google Scholar
• Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res 2011;30:343–358.
   PubMed Web of Science ®Google Scholar
• Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 2011;52:1156–1163.
   PubMed Web of Science ®Google Scholar
• Liu R, Li X, Zhang X. Dexmedetomidine protects high-glucose induced apoptosis in human retinal pigment epithelial cells through inhibition on p75(NTR). Biomed Pharmacother 2018;106:466–471.
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615–1625.
   PubMed Web of Science ®Google Scholar
• Trudeau K, Molina AJ, Guo W, Roy S. High glucose disrupts mitochondrial morphology in retinal endothelial cells: implications for diabetic retinopathy. Am J Pathol 2010;177:447–455.
   PubMed Web of Science ®Google Scholar
• Trudeau K, Molina AJ, Roy S. High glucose induces mitochondrial morphology and metabolic changes in retinal pericytes. Invest Ophthalmol Vis Sci 2011;52:8657–8664.
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Mishra M. Oxidative stress, mitochondrial damage and diabetic retinopathy. Biochim Biophys Acta 2015;1852:2474–2483.
   PubMed Web of Science ®Google Scholar
• Roy S, Kern TS, Song B, Stuebe C. Mechanistic insights into pathological changes in the diabetic retina: implications for targeting diabetic retinopathy. Am J Pathol 2017;187:9–19.
   PubMed Web of Science ®Google Scholar
• Eells JT. Mitochondrial dysfunction in the aging retina. Biology 2019;8:31.
   PubMed Web of Science ®Google Scholar
• Galimov ER. The role of p66shc in oxidative stress and apoptosis. Acta Naturae 2010;2:44–51.
   PubMed Web of Science ®Google Scholar
• Yang H, Yao P, Li R, Zhang X. Inhibition of P66shc-induced oxidative stress protects against rat diabetic retinopathy. Int J Clin Exp Med 2017;10:15704–15712.
   Web of Science ®Google Scholar
• Giorgio M, Migliaccio E, Orsini F, et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005;122:221–233.
   PubMed Web of Science ®Google Scholar
• Trinei M, Giorgio M, Cicalese A, et al. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 2002;21:3872–3878.
   PubMed Web of Science ®Google Scholar
• Zhu M, Chen J, Wen M, et al. Propofol protects against angiotensin II-induced mouse hippocampal HT22 cells apoptosis via inhibition of p66Shc mitochondrial translocation. Neuromolecular Med 2014;16:772–781.
   PubMed Web of Science ®Google Scholar
• Le S, Connors TJ, Maroney AC. c-Jun N-terminal kinase specifically phosphorylates p66ShcA at serine 36 in response to ultraviolet irradiation. J Biol Chem 2001;276:48332–48336.
   PubMed Web of Science ®Google Scholar
• De Marchi E, Baldassari F, Bononi A, et al. Oxidative stress in cardiovascular diseases and obesity: role of p66Shc and protein kinase C. Oxid Med Cell Longev 2013;2013:564961
   PubMed Web of Science ®Google Scholar
• Migliaccio E, Giorgio M, Mele S, et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999;402:309–313.
   PubMed Web of Science ®Google Scholar
• Menini S, Amadio L, Oddi G, et al. Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes 2006;55:1642–1650.
   PubMed Web of Science ®Google Scholar
• Sun L, Xiao L, Nie J, et al. p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathway. Am J Physiol Renal Physiol 2010;299:F1014–F1025.
   PubMed Web of Science ®Google Scholar
• Zhou S, Chen HZ, Wan YZ, et al. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res 2011;109:639–648.
   PubMed Web of Science ®Google Scholar
• Diogo CV, Suski JM, Lebiedzinska M, et al. Cardiac mitochondrial dysfunction during hyperglycemia–the role of oxidative stress and p66Shc signaling. Int J Biochem Cell Biol 2013;45:114–122.
   PubMed Web of Science ®Google Scholar
• Wu Z, Rogers B, Kachi S, et al. Reduction of p66Shc suppresses oxidative damage in retinal pigmented epithelial cells and retina. J Cell Physiol 2006;209:996–1005.
   PubMed Web of Science ®Google Scholar
• Zhao MH, Hu J, Li S, et al. P66Shc expression in diabetic rat retina. BMC Ophthalmol 2018;18:58
   PubMed Web of Science ®Google Scholar
• Buteau J, Roduit R, Susini S, Prentki M. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells. Diabetologia 1999;42:856–864.
   PubMed Web of Science ®Google Scholar
• Bose AK, Mocanu MM, Carr RD, et al. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes 2005;54:146–151.
   PubMed Web of Science ®Google Scholar
• Meloni AR, DeYoung MB, Lowe C, Parkes DG. GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence. Diabetes Obes Metab 2013;15:15–27.
   PubMed Web of Science ®Google Scholar
• Cai X, Li J, Wang M, et al. GLP-1 treatment improves diabetic retinopathy by alleviating autophagy through GLP-1R-ERK1/2-HDAC6 Signaling Pathway. Int J Med Sci 2017;14:1203–1212.
   PubMed Web of Science ®Google Scholar
• Wei Q, Sun YQ, Zhang J. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line. Peptides 2012;37:18–24.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Q, Zhang J, et al. Protection of exendin-4 analogue in early experimental diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2009;247:699–706.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang J, Wang Q, et al. Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats. Invest Ophthalmol Vis Sci 2011;52:278–285.
   PubMed Web of Science ®Google Scholar
• Fu Z, Kuang HY, Hao M, et al. Protection of exenatide for retinal ganglion cells with different glucose concentrations. Peptides 2012;37:25–31.
   PubMed Web of Science ®Google Scholar
• Simo R, Hernandez C. GLP-1R as a target for the treatment of diabetic retinopathy: friend or foe? Diabetes 2017;66:1453–1460.
   PubMed Web of Science ®Google Scholar
• Kim DI, Park MJ, Lim SK, Choi JH, et al. High-glucose-induced CARM1 expression regulates apoptosis of human retinal pigment epithelial cells via histone 3 arginine 17 dimethylation: role in diabetic retinopathy. Arch Biochem Biophys 2014;560:36–43.
   PubMed Web of Science ®Google Scholar
• Chang KC, Snow A, LaBarbera DV, Petrash JM. Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells. Chem Biol Interact 2015;234:254–260.
   PubMed Web of Science ®Google Scholar
• Lin X, Zhou X, Liu D, et al. MicroRNA-29 regulates high-glucose-induced apoptosis in human retinal pigment epithelial cells through PTEN. In Vitro Cell Dev Biol Anim 2016;52:419–426.
   PubMed Web of Science ®Google Scholar
• Fan Y, Liu K, Wang Q, et al. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats. Exp Eye Res 2014;127:104–116.
   PubMed Web of Science ®Google Scholar
• Hernandez C, Bogdanov P, Corraliza L, et al. Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes. Diabetes 2016;65:172–187.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Yang K, Wang F, et al. The glucagon like peptide 1 analogue, exendin-4, attenuates oxidative stress-induced retinal cell death in early diabetic rats through promoting Sirt1 and Sirt3 expression. Exp Eye Res 2016;151:203–211.
   PubMed Web of Science ®Google Scholar
• Hao M, Kuang HY, Fu Z, et al. Exenatide prevents high-glucose-induced damage of retinal ganglion cells through a mitochondrial mechanism. Neurochem Int 2012;61:1–6.
   PubMed Web of Science ®Google Scholar
• Strauss O. The retinal pigment epithelium in visual function. Physiol Rev 2005;85:845–881.
   PubMed Web of Science ®Google Scholar
• Simo R, Villarroel M, Corraliza L, et al. The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier-implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol 2010;2010:190724.
   PubMedGoogle Scholar
• Behl Y, Krothapalli P, Desta T, et al. Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol 2008;172:1411–1418.
   PubMed Web of Science ®Google Scholar
• Gonzalez de Vega R, Garcia M, Fernandez-Sanchez ML, et al. Protective effect of selenium supplementation following oxidative stress mediated by glucose on retinal pigment epithelium. Metallomics 2018;10:83–92.
   PubMed Web of Science ®Google Scholar
• Shi Y, Zhang Y, Li Y, Tong C. Sauchinone inhibits high glucose-induced oxidative stress and apoptosis in retinal pigment epithelial cells. RSC Adv 2019;9:17065–17071.
   PubMed Web of Science ®Google Scholar
• Fan Y, Liu K, Wang Q, et al. Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis. Mol Vis 2014;20:1557–1568.
   PubMed Web of Science ®Google Scholar
• Hölscher C. Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection. CNS Drugs 2012;26:871–882.
   PubMed Web of Science ®Google Scholar
• Yarchoan M, Arnold SE. Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease. Diabetes 2014;63:2253–2261.
   PubMed Web of Science ®Google Scholar
• Timmers L, Henriques JP, de Kleijn DP, et al. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. J Am Coll Cardiol 2009;53:501–510.
   PubMed Web of Science ®Google Scholar
• Lee KH, Cho H, Lee S, et al. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity. Int J Cardiol 2017;232:40–47.
   PubMed Web of Science ®Google Scholar
• Ding W, Chang WG, Guo XC, et al. Exenatide protects against cardiac dysfunction by attenuating oxidative stress in the diabetic mouse heart. Front Endocrinol (Lausanne) 2019;10:202
   PubMed Web of Science ®Google Scholar
• Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058–1070.
   PubMed Web of Science ®Google Scholar
• Safi SZ, Qvist R, Kumar S, et al. Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. Biomed Res Int 2014;2014:801269.
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787–790.
   PubMed Web of Science ®Google Scholar
• Du XL, Edelstein D, Rossetti L, et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 2000;97:12222–12226.
   PubMed Web of Science ®Google Scholar
• Aoki H, Kang PM, Hampe J, et al. Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J Biol Chem 2002;277:10244–10250.
   PubMed Web of Science ®Google Scholar
• Dougherty CJ, Kubasiak LA, Frazier DP, et al. Mitochondrial signals initiate the activation of c-Jun N-terminal kinase (JNK) by hypoxia-reoxygenation. Faseb j 2004;18:1060–1070.
   PubMed Web of Science ®Google Scholar
• Chambers JW, Pachori A, Howard S, et al. Inhibition of JNK mitochondrial localization and signaling is protective against ischemia/reperfusion injury in rats. J Biol Chem 2013;288:4000–4011.
   PubMed Web of Science ®Google Scholar
• Shvedova M, Anfinogenova Y, Atochina-Vasserman EN, Schepetkin IA, Atochin DN. c-Jun N-terminal kinases (JNKs) in myocardial and cerebral ischemia/reperfusion injury. Front Pharmacol 2018;9:715.
   PubMed Web of Science ®Google Scholar
• Mishra M, Duraisamy AJ, Bhattacharjee S, Kowluru RA. Adaptor protein p66Shc: a link between cytosolic and mitochondrial dysfunction in the development of diabetic retinopathy. Antioxid Redox Signal 2019;30:1621–1634.
   PubMed Web of Science ®Google Scholar
• Kim JY, Lim DM, Moon CI, et al. Exendin-4 protects oxidative stress-induced β-cell apoptosis through reduced JNK and GSK3β activity. J Korean Med Sci 2010;25:1626–1632.
   PubMed Web of Science ®Google Scholar